Form 4: Allarity Therapeutics Executive Reports Stock Transaction
Insider Transaction (Form 4)
Jeremy R. Graff, See Remarks of Allarity Therapeutics, Inc., reported multiple transactions in common stock on January 22, 2026.
Summary
- Option exercise/conversion: acquired 48,147 Common Stock on January 22, 2026; holds 73,028 after (Direct).
- Tax/exercise-price withholding: disposed of 17,814 Common Stock at $1.18 ($21,021) on January 22, 2026; holds 55,214 after (Direct).
- Option exercise/conversion: acquired 39,494 Common Stock on September 30, 2026; holds 94,708 after (Direct).
- Tax/exercise-price withholding: disposed of 14,613 Common Stock at $0.97 ($14,175) on September 30, 2026; holds 80,095 after (Direct).
- Option exercise/conversion: disposed of 48,147 Restricted Stock Units on January 22, 2026; holds 175,283 after (Direct).
- Option exercise/conversion: disposed of 39,494 Restricted Stock Units on September 30, 2026; holds 269,122 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jeremy R. Graff — Officer (See Remarks)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-01-22 | Option exercise/conversion | Common Stock | 48,147 | — | — | 73,028 |
| 2026-01-22 | Tax/exercise-price withholding | Common Stock | 17,814 | $1 | $21.0K | 55,214 |
| 2026-09-30 | Option exercise/conversion | Common Stock | 39,494 | — | — | 94,708 |
| 2026-09-30 | Tax/exercise-price withholding | Common Stock | 14,613 | $1 | $14.2K | 80,095 |
| 2026-01-22 | Option exercise/conversion | Restricted Stock Units | 48,147 | — | — | 175,283 |
| 2026-09-30 | Option exercise/conversion | Restricted Stock Units | 39,494 | — | — | 269,122 |
Key Dates
| Date | Description |
|---|---|
| 2026-01-22 | Option exercise/conversion (48,147 shares) |
| 2026-01-22 | Tax/exercise-price withholding (17,814 shares) |
| 2026-09-30 | Option exercise/conversion (39,494 shares) |
| 2026-09-30 | Tax/exercise-price withholding (14,613 shares) |
| 2026-01-22 | Option exercise/conversion (48,147 shares) |
| 2026-09-30 | Option exercise/conversion (39,494 shares) |
Keywords
insider transaction, Form 4, ALLR, Allarity Therapeutics, Inc., neutral, Jeremy R. Graff
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.